Nrg1 Fusion-positive Solid Tumors
📧 Sign up to get email alerts when something new happens for Nrg1 Fusion-positive Solid Tumors.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-12-04FDA Approved: BIZENGRI — Original Application (Merus US, Inc.)
The FDA approved Bizengri (zenocutuzumab) from Merus US, Inc. in an Original Application for adult patients with NRG1 fusion-positive solid …